Roger L. Albin

46.4k total citations · 5 hit papers
315 papers, 21.8k citations indexed

About

Roger L. Albin is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Roger L. Albin has authored 315 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Neurology, 152 papers in Cellular and Molecular Neuroscience and 88 papers in Molecular Biology. Recurrent topics in Roger L. Albin's work include Parkinson's Disease Mechanisms and Treatments (114 papers), Neurological disorders and treatments (99 papers) and Neuroscience and Neuropharmacology Research (80 papers). Roger L. Albin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (114 papers), Neurological disorders and treatments (99 papers) and Neuroscience and Neuropharmacology Research (80 papers). Roger L. Albin collaborates with scholars based in United States, Italy and Netherlands. Roger L. Albin's co-authors include John B. Penney, Anne B. Young, Kirk A. Frey, Nicolaas I. Bohnen, Robert A. Koeppe, Martijn L.T.M. Müller, J. Timothy Greenamyre, Vikas Kotagal, Karen E. Anderson and A. Byron Young and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Roger L. Albin

310 papers receiving 21.4k citations

Hit Papers

The functional anatomy of basal ganglia disorders 1988 2026 2000 2013 1989 1988 1992 2020 2022 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The functional anatomy of basal ganglia disorders
    1989 3.9k citations Roger L. Albin et al. profile →
  2. Differential loss of striatal projection neurons in Huntington disease.
    1988 777 citations Roger L. Albin et al. profile →
  3. Alternative excitotoxic hypotheses
    1992 457 citations Roger L. Albin et al. Neurology profile →
  4. Current and projected future economic burden of Parkinson’s disease in the U.S.
    2020 397 citations Roger L. Albin et al. profile →
  5. Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
    2022 145 citations Nicolaas I. Bohnen, Roger L. Albin et al. profile →

Peers

Roger L. Albin
A. Jon Stoessl Canada
Jeffrey H. Kordower United States
Udo Rüb Germany
Thomas Klockgether Germany
Stephen J. Kish Canada
José Á. Obeso Spain
Erwan Bézard France
Sarah J. Tabrizi United Kingdom
Oleh Hornykiewicz Austria
Stanley Fahn United States
A. Jon Stoessl Canada
Roger L. Albin
Citations per year, relative to Roger L. Albin Roger L. Albin (= 1×) peers A. Jon Stoessl

Countries citing papers authored by Roger L. Albin

Since Specialization
Citations

This map shows the geographic impact of Roger L. Albin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Albin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Albin more than expected).

Fields of papers citing papers by Roger L. Albin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. Albin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Albin. The network helps show where Roger L. Albin may publish in the future.

Co-authorship network of co-authors of Roger L. Albin

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Albin. A scholar is included among the top collaborators of Roger L. Albin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Albin. Roger L. Albin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chou, Kelvin L., et al.. (2025). Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease. Movement Disorders. 40(8). 1584–1594.
2.
Bohnen, Nicolaas I., Sygrid van der Zee, Kirk A. Frey, et al.. (2025). A multicenter longitudinal study of cholinergic subgroups in Parkinson disease. Nature Communications. 16(1). 5655–5655. 1 indexed citations
3.
Bohnen, Nicolaas I., Uroš Marušič, Peter J. H. Scott, et al.. (2024). Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patterns. Brain Communications. 6(5). fcae286–fcae286. 1 indexed citations
4.
Albin, Roger L., et al.. (2024). Update: Protective and risk factors for Parkinson disease. Parkinsonism & Related Disorders. 125. 107026–107026. 8 indexed citations
5.
Albin, Roger L., et al.. (2024). Update: Descriptive epidemiology of Parkinson disease. Parkinsonism & Related Disorders. 120. 106000–106000. 20 indexed citations
6.
Iordan, Alexandru D., Robert Ploutz‐Snyder, Bidisha Ghosh, et al.. (2024). Salience network segregation mediates the effect of tau pathology on mild behavioral impairment. Alzheimer s & Dementia. 20(11). 7675–7685. 2 indexed citations
7.
Wang, Xin, Kelly M. Bakulski, Carrie Karvonen‐Gutierrez, et al.. (2023). Blood‐based biomarkers for Alzheimer's disease and cognitive function from mid‐ to late life. Alzheimer s & Dementia. 20(3). 1807–1814. 9 indexed citations
8.
Zee, Sygrid van der, Giulia Carli, Jeffrey M. Boertien, et al.. (2023). Cholinergic innervation topography in GBA-associated de novo Parkinson’s disease patients. Brain. 147(3). 900–910. 11 indexed citations
9.
Burke, James, Kevin A. Kerber, Kenneth M. Langa, Roger L. Albin, & Vikas Kotagal. (2023). Lecanemab. Neurology. 101(15). 661–665. 40 indexed citations
10.
Kanel, Prabesh, Robert A. Koeppe, Vikas Kotagal, et al.. (2023). Regional serotonin terminal density in aging human brain: A [11C]DASB PET study. SHILAP Revista de lepidopterología. 3. 100071–100071. 1 indexed citations
11.
Albin, Roger L., et al.. (2023). What is the Parkinson Pandemic?. Movement Disorders. 38(12). 2141–2144. 6 indexed citations
12.
Albin, Roger L., Prabesh Kanel, Teus van Laar, et al.. (2022). No Dopamine Agonist Modulation of Brain [18F]FEOBV Binding in Parkinson’s Disease. Molecular Pharmaceutics. 19(4). 1176–1182. 5 indexed citations
13.
Albin, Roger L., Martijn L.T.M. Müller, Nicolaas I. Bohnen, et al.. (2021). α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders. Annals of Neurology. 90(1). 130–142. 15 indexed citations
14.
Albin, Roger L., Nicolaas I. Bohnen, Martijn L.T.M. Müller, et al.. (2018). Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography study. The Journal of Comparative Neurology. 526(17). 2884–2897. 50 indexed citations
15.
Albin, Roger L., et al.. (2017). Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome. eNeuro. 4(4). ENEURO.0178–17.2017. 11 indexed citations
16.
Tallaksen‐Greene, Sara J., Marianna Sadagurski, Li Zeng, et al.. (2014). Differential Effects of Delayed Aging on Phenotype and Striatal Pathology in a Murine Model of Huntington Disease. Journal of Neuroscience. 34(47). 15658–15668. 12 indexed citations
17.
Bohnen, Nicolaas I., Robert A. Koeppe, Satoshi Minoshima, et al.. (2011). Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study. Journal of Nuclear Medicine. 52(6). 848–855. 172 indexed citations
18.
Heng, Mary Y., et al.. (2009). In VivoEvidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease. Journal of Neuroscience. 29(10). 3200–3205. 89 indexed citations
19.
Kearney, Jennifer A., Kirk A. Frey, & Roger L. Albin. (1997). Metabotropic Glutamate Agonist-Induced Rotation: A Pharmacological, FOS Immunohistochemical, and [14C]-2-Deoxyglucose Autoradiographic Study. Journal of Neuroscience. 17(11). 4415–4425. 74 indexed citations
20.
Albin, Roger L., et al.. (1979). Diagnosis and treatment of pansinusitis: report of case.. PubMed. 37(8). 604–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Jon Stoessl Breakdown of academic impact, for papers by Jeffrey H. Kordower Breakdown of academic impact, for papers by Udo Rüb Breakdown of academic impact, for papers by Thomas Klockgether Breakdown of academic impact, for papers by Stephen J. Kish Breakdown of academic impact, for papers by José Á. Obeso Breakdown of academic impact, for papers by Erwan Bézard Breakdown of academic impact, for papers by Sarah J. Tabrizi Breakdown of academic impact, for papers by Oleh Hornykiewicz Breakdown of academic impact, for papers by Stanley Fahn
Rankless by CCL
2026